{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62938-0029",
      "generic_name": "selegiline hydrochloride",
      "labeler_name": "CATALENT U.K. SWINDON ZYDIS LIMITED",
      "active_ingredients": [
        {
          "name": "SELEGILINE HYDROCHLORIDE",
          "strength": "1.25 mg/1"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "62938-0029-1",
          "description": "630 BLISTER PACK in 1 BOX (62938-0029-1)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
          "marketing_start_date": "14-JUN-06"
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "TABLET, ORALLY DISINTEGRATING",
      "spl_id": "49855971-8e44-2128-e063-6294a90a5aa8",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20060614",
      "product_id": "62938-0029_49855971-8e44-2128-e063-6294a90a5aa8",
      "brand_name_base": null
    }
  ]
}